Promise Details
Kennedy promised to rapidly expand U.S. infant formula manufacturing capacity and simplify FDA approval for imported formula through “Operation Stork Speed.” The goal was to prevent future shortages and diversify supply. Despite initial progress, production delays, regulatory bottlenecks, and poor coordination between HHS and USDA slowed the rollout. Parents’ groups accused the administration of overpromising and underdelivering. By mid-2025, only one new facility had opened instead of the planned five.
Why it is broken
Operation Stork Speed launched with fanfare but quickly encountered manufacturing and coordination issues. FDA slow-tracked import approvals, and supply-chain partners withdrew from early contracts. Only one new plant became operational out of the five promised. Parent advocacy groups and lawmakers decried the delays as avoidable mismanagement. The effort delivered minor relief but fell short of its nationwide expansion goals, classifying it as a broken promise.
Sources
The information presented in this promise is aggregated from various publicly available sources. We do not claim ownership or guarantee the accuracy of the content. All data is collected and cross-validated from multiple independent sources. To read more about this promise, please view the source links below:
Support Our Work
Help us keep the website running and free for everyone by supporting us:
